UPenn Perelman School of Medicine: New Drug Shows Promise Against Autoimmune Skin Disease
August 17, 2022
August 17, 2022
UNIVERSITY CITY, Pennsylvania, Aug. 17 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Clinical trial brings hope for those with cutaneous lupus erythematosus, Penn Medicine researchers find
* * *
An experimental drug called litifilimab (known as BIIB059) could be a powerful long-term treatment for cutaneous lupus erythematosus (CLE), a form of lupus that occurs in the skin . . .
* * *
Clinical trial brings hope for those with cutaneous lupus erythematosus, Penn Medicine researchers find
* * *
An experimental drug called litifilimab (known as BIIB059) could be a powerful long-term treatment for cutaneous lupus erythematosus (CLE), a form of lupus that occurs in the skin . . .